| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4349559
[patent_doc_number] => 06214791
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1'
[patent_app_type] => 1
[patent_app_number] => 9/341369
[patent_app_country] => US
[patent_app_date] => 2000-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 5393
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214791.pdf
[firstpage_image] =>[orig_patent_app_number] => 341369
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341369 | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | Jan 11, 2000 | Issued |
Array
(
[id] => 4241806
[patent_doc_number] => 06221389
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Aqueous carrier systems for water-insoluble materials'
[patent_app_type] => 1
[patent_app_number] => 9/445343
[patent_app_country] => US
[patent_app_date] => 2000-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11912
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221389.pdf
[firstpage_image] =>[orig_patent_app_number] => 445343
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445343 | Aqueous carrier systems for water-insoluble materials | Jan 10, 2000 | Issued |
| 09/462060 | USE OF ALKANOYL CARNITINE DERIVATIVES FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVE DISORDERS | Jan 2, 2000 | Abandoned |
Array
(
[id] => 4104182
[patent_doc_number] => 06100297
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution'
[patent_app_type] => 1
[patent_app_number] => 9/470731
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2653
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/100/06100297.pdf
[firstpage_image] =>[orig_patent_app_number] => 470731
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/470731 | Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution | Dec 21, 1999 | Issued |
| 09/468835 | PHARMACEUTICAL COMPOSITION | Dec 21, 1999 | Abandoned |
Array
(
[id] => 4315266
[patent_doc_number] => 06242492
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'N,N\'-bis(2-hydroxybenzyl)ethylenediamine-N,N\'-diacetic acid in iron chelating therapy'
[patent_app_type] => 1
[patent_app_number] => 9/467943
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6226
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242492.pdf
[firstpage_image] =>[orig_patent_app_number] => 467943
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/467943 | N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid in iron chelating therapy | Dec 20, 1999 | Issued |
Array
(
[id] => 4304874
[patent_doc_number] => 06187793
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => '7-[(Piperidin-1-YL)-Propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use'
[patent_app_type] => 1
[patent_app_number] => 9/380092
[patent_app_country] => US
[patent_app_date] => 1999-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3700
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187793.pdf
[firstpage_image] =>[orig_patent_app_number] => 380092
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/380092 | 7-[(Piperidin-1-YL)-Propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use | Dec 20, 1999 | Issued |
Array
(
[id] => 4160885
[patent_doc_number] => 06156941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Process for producing 1,2-propanediol'
[patent_app_type] => 1
[patent_app_number] => 9/423980
[patent_app_country] => US
[patent_app_date] => 1999-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2814
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156941.pdf
[firstpage_image] =>[orig_patent_app_number] => 423980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423980 | Process for producing 1,2-propanediol | Dec 19, 1999 | Issued |
Array
(
[id] => 4297344
[patent_doc_number] => 06251439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Composition and method for reducing the risk of carcinogenesis'
[patent_app_type] => 1
[patent_app_number] => 9/464047
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7936
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251439.pdf
[firstpage_image] =>[orig_patent_app_number] => 464047
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464047 | Composition and method for reducing the risk of carcinogenesis | Dec 14, 1999 | Issued |
Array
(
[id] => 4315128
[patent_doc_number] => 06242483
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Selectively cytotoxic acetogenin compounds'
[patent_app_type] => 1
[patent_app_number] => 9/423139
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6650
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242483.pdf
[firstpage_image] =>[orig_patent_app_number] => 423139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423139 | Selectively cytotoxic acetogenin compounds | Dec 14, 1999 | Issued |
Array
(
[id] => 4132563
[patent_doc_number] => 06147049
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Tetra-hydronaphthalenes'
[patent_app_type] => 1
[patent_app_number] => 9/460248
[patent_app_country] => US
[patent_app_date] => 1999-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2052
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147049.pdf
[firstpage_image] =>[orig_patent_app_number] => 460248
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/460248 | Tetra-hydronaphthalenes | Dec 12, 1999 | Issued |
Array
(
[id] => 4291514
[patent_doc_number] => 06235709
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Inhibitor of helicobacter pylori colonization'
[patent_app_type] => 1
[patent_app_number] => 9/458996
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5935
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235709.pdf
[firstpage_image] =>[orig_patent_app_number] => 458996
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458996 | Inhibitor of helicobacter pylori colonization | Dec 9, 1999 | Issued |
Array
(
[id] => 1388176
[patent_doc_number] => 06548490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction'
[patent_app_type] => B1
[patent_app_number] => 09/467094
[patent_app_country] => US
[patent_app_date] => 1999-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8808
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09467094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/467094 | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction | Dec 9, 1999 | Issued |
Array
(
[id] => 4260218
[patent_doc_number] => 06204248
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Pharmaceutical preparations of glutathione and methods of administration thereof'
[patent_app_type] => 1
[patent_app_number] => 9/457642
[patent_app_country] => US
[patent_app_date] => 1999-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41340
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204248.pdf
[firstpage_image] =>[orig_patent_app_number] => 457642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/457642 | Pharmaceutical preparations of glutathione and methods of administration thereof | Dec 8, 1999 | Issued |
Array
(
[id] => 4412268
[patent_doc_number] => 06229010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Polymorphic form of a tachykinin receptor antagonist'
[patent_app_type] => 1
[patent_app_number] => 9/458168
[patent_app_country] => US
[patent_app_date] => 1999-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20539
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/229/06229010.pdf
[firstpage_image] =>[orig_patent_app_number] => 458168
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/458168 | Polymorphic form of a tachykinin receptor antagonist | Dec 8, 1999 | Issued |
| 09/319565 | FORMULATIONS AND POLYMORPHIC FORMS OF DESFERRIOXAMINE AND THE PREPARATION THEREOF | Dec 5, 1999 | Abandoned |
Array
(
[id] => 1528429
[patent_doc_number] => 06479521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-12
[patent_title] => 'Use of 2-mercapto-pyridine-N-oxide'
[patent_app_type] => B2
[patent_app_number] => 09/445330
[patent_app_country] => US
[patent_app_date] => 1999-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1031
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479521.pdf
[firstpage_image] =>[orig_patent_app_number] => 09445330
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445330 | Use of 2-mercapto-pyridine-N-oxide | Dec 5, 1999 | Issued |
Array
(
[id] => 1222915
[patent_doc_number] => 06699496
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form'
[patent_app_type] => B1
[patent_app_number] => 09/453487
[patent_app_country] => US
[patent_app_date] => 1999-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4296
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699496.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453487
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453487 | Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form | Dec 2, 1999 | Issued |
| 09/424973 | USE OF ANTI-INFLAMMATORY STEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL DISEASES | Dec 2, 1999 | Abandoned |
Array
(
[id] => 1528454
[patent_doc_number] => 06479533
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Methods and compositions for the protection of mitochondria'
[patent_app_type] => B1
[patent_app_number] => 09/452585
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5714
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479533.pdf
[firstpage_image] =>[orig_patent_app_number] => 09452585
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/452585 | Methods and compositions for the protection of mitochondria | Nov 30, 1999 | Issued |